February 5, 2024 by Bill Schiffner
Lifelab’s new HoneyWorks Plus offers ‘more with less’
February 5, 2024, Supplier News
COCONUT CREEK, Fla. — The cold and flu category continues to grow as people return to work in offices across the country, noted Lou Machin, managing director at Lifelab Health. “There is a trend to over-medicate as office workers are experiencing ‘sick shaming’ due to continuing concerns over COVID variants on the scene,” he pointed
February 5, 2024 by Bill Schiffner
Boiron meets increasing demand for natural O-T-Cs
February 5, 2024, Supplier News
NEWTON SQUARE, Pa. — The current cough and cold season started very slowly and began accelerating in late December. With the late start the category is still seeing strong numbers in January. “The previous year, the season started in late September and only went through December. The cough and cold category is now trying to
February 5, 2024 by Bill Schiffner
Whole Foods rolls out Genexa’s ‘clean label’ products
February 5, 2024, Retail News, Supplier News
ATLANTA — As we move into the 2024 cold and flu season, Genexa is reinforcing its pioneering role in bringing clean, effective medicines to consumers. “This cough/cold/flu season we’re seeing more consumers stocking up on several solutions for their family, often building baskets that consist of a conventional over-the-counter drug along with a non-drug solution,
February 5, 2024 by Stephen Ubl
Stephen Ubl is president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA).
February 5, 2024, Opinion, Pharmacy
The last year has been remarkable for medical advancement, and with thousands of therapies in the development pipeline, 2024 promises to be just as exciting. New CAR-T treatments, which use the body’s immune system to kill cancer cells, now help patients fight advanced-stage leukemia, with success rates of up to 94%. Genetic treatments give vision
February 5, 2024 by David Pinto
It’s time to rediscover the lost art of merchandising
February 5, 2024, Opinion
Once upon a time in America, the nation’s three most important drug chains — CVS, Rite Aid and Walgreens — succeeded as much for the zeal, creativity and accomplishments of their chief merchants as for the directions provided by their senior management. Indeed, it was a time when people like Vern Brunner, Chris Bodine and
February 2, 2024 by Pamela Long
Pamela Long is a partner at Big Little Brands.
February 5, 2024, Supplier News
Picture this. It’s February, freezing cold outside, you’re bundled up, you’re wearing a mask and trying to keep your glasses from fogging up. You’re sneezing, coughing, aching, your head hurts, and you feel fuzzy and incapable of thinking or doing. You’re desperate for relief, and you’re facing a shelf of mass confusion. Oh, and there
January 30, 2024 by Jeffrey Woldt
CVS is fully capitalizing on retail media
February 5, 2024, Leading Headlines, Opinion
Like most major retailers, CVS Pharmacy has entered the media business with the intent of broadening and deepening consumer engagement, working with CPG companies to better serve shoppers and grow categories, and establishing a new revenue stream. CVS Media Exchange, or CMX, is leading the charge, teaming up with suppliers and developing targeted, omnichannel campaigns